STOCK TITAN

Ameriprise details 10.7% Quanterix (QTRX) ownership in Schedule 13G/A

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Quanterix Corp. received an amended Schedule 13G/A showing that a group of affiliated Ameriprise entities collectively report beneficial ownership of 4,996,073 shares of Quanterix common stock, representing 10.7% of the class as of 12/31/2025.

The filing lists Ameriprise Financial, Inc. and multiple UK- and Luxembourg-based subsidiaries with shared voting and dispositive power over these shares. The Ameriprise entities state the holdings are maintained in the ordinary course of business and not for the purpose of changing or influencing control of Quanterix.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Ameriprise Financial, Inc.
Signature:/s/ Michael G. Clarke
Name/Title:Michael G. Clarke, Senior Vice President, North America Head of Operations & Investor Services
Date:02/17/2026
TAM UK International Holdings Limited
Signature:/s/ Michael G. Clarke
Name/Title:By: Columbia Mgmt. Investment Advisers, LLC, as Attorney in Fact, By: Michael G. Clarke, SVP, North America Head of Operations & Investor Services
Date:02/17/2026
Threadneedle Holdings Limited
Signature:/s/ Michael G. Clarke
Name/Title:By: Columbia Mgmt. Investment Advisers, LLC, as Attorney in Fact, By: Michael G. Clarke, SVP, North America Head of Operations & Investor Services
Date:02/17/2026
TAM UK Holdings Limited
Signature:/s/ Michael G. Clarke
Name/Title:By: Columbia Mgmt. Investment Advisers, LLC, as Attorney in Fact, By: Michael G. Clarke, SVP, North America Head of Operations & Investor Services
Date:02/17/2026
Threadneedle Asset Management Holdings Limited
Signature:/s/ Michael G. Clarke
Name/Title:By: Columbia Mgmt. Investment Advisers, LLC, as Attorney in Fact, By: Michael G. Clarke, SVP, North America Head of Operations & Investor Services
Date:02/17/2026
TC Financing Ltd
Signature:/s/ Michael G. Clarke
Name/Title:By: Columbia Mgmt. Investment Advisers, LLC, as Attorney in Fact, By: Michael G. Clarke, SVP, North America Head of Operations & Investor Services
Date:02/17/2026
Threadneedle Asset Management Limited
Signature:/s/ Michael G. Clarke
Name/Title:By: Columbia Mgmt. Investment Advisers, LLC, as Attorney in Fact, By: Michael G. Clarke, SVP, North America Head of Operations & Investor Services
Date:02/17/2026
Threadneedle Investment Services Limited
Signature:/s/ Michael G. Clarke
Name/Title:By: Columbia Mgmt. Investment Advisers, LLC, as Attorney in Fact, By: Michael G. Clarke, SVP, North America Head of Operations & Investor Services
Date:02/17/2026
Threadneedle Management Luxembourg S.A.
Signature:/s/ Michael G. Clarke
Name/Title:By: Columbia Mgmt. Investment Advisers, LLC, as Attorney in Fact, By: Michael G. Clarke, SVP, North America Head of Operations & Investor Services
Date:02/17/2026

Comments accompanying signature: Contact Information Charles Chiesa VP Fund Treasurer Global Operations and Investor Services Telephone: 617-385-9593
Exhibit Information

Exhibit Index Exhibit I Identification and Classification of the Subsidiaries which Acquired the Security Being Reported on by the Parent Holding Company. Exhibit II Joint Filing Agreement Exhibit III Powers of Attorney

FAQ

What does the Ameriprise Schedule 13G/A reveal about Quanterix (QTRX)?

The filing shows Ameriprise entities beneficially own 4,996,073 Quanterix common shares, or 10.7% of the class, as of 12/31/2025. The stake is reported as held in the ordinary course of business, without the stated intent to influence or change control of Quanterix.

Which Ameriprise entities report ownership in Quanterix (QTRX)?

Ameriprise Financial, Inc. and several affiliates, including UK International Holdings Limited and Threadneedle-branded UK and Luxembourg entities, report Quanterix holdings. Together, these "Ameriprise Entities" disclose shared voting and dispositive power over the reported shares, with Ameriprise Financial deemed to beneficially own shares held by its subsidiaries.

How large is Ameriprise’s reported stake in Quanterix (QTRX)?

Ameriprise entities report beneficial ownership of 4,996,073 Quanterix common shares, representing 10.7% of the outstanding class as of 12/31/2025. Individual subsidiaries show portions of this stake, such as 3,122,967 shares or 6.7% and 1,894,013 shares or 4.1%, under shared voting and dispositive power.

Is Ameriprise seeking control of Quanterix (QTRX) with this ownership?

The Ameriprise entities certify the Quanterix shares were acquired and are held in the ordinary course of business, not to change or influence control of the issuer. They also state the holdings are not connected with any transaction intended to affect control, other than limited proxy nomination activities referenced in regulations.

What type of SEC filing is this for Quanterix (QTRX)?

This is an Amendment No. 4 to a Schedule 13G, a passive ownership report. It updates beneficial ownership information for Quanterix common stock by Ameriprise and related entities as of 12/31/2025, detailing share counts, voting power, and percentage of the class for each reporting person.

Who signed the Ameriprise ownership filing for Quanterix (QTRX)?

The statement is signed by Michael G. Clarke, Senior Vice President and North America Head of Operations & Investor Services. Several signatures are executed on behalf of Ameriprise-related entities via Columbia Mgmt. Investment Advisers, LLC acting under powers of attorney referenced in the exhibit index.
Quanterix

NASDAQ:QTRX

QTRX Rankings

QTRX Latest News

QTRX Latest SEC Filings

QTRX Stock Data

269.05M
41.26M
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA